Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1985 1
1990 2
1991 3
1992 2
1993 1
1994 5
1995 5
1996 11
1997 11
1998 12
1999 4
2000 4
2001 4
2002 6
2003 3
2004 5
2005 3
2006 9
2007 7
2008 6
2009 9
2010 4
2011 6
2012 12
2013 17
2014 17
2015 16
2016 17
2017 15
2018 18
2019 17
2020 23
2021 22
2022 14
2023 16
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Results by year

Filters applied: . Clear all
Page 1
Neurotrophic keratopathy.
Dua HS, Said DG, Messmer EM, Rolando M, Benitez-Del-Castillo JM, Hossain PN, Shortt AJ, Geerling G, Nubile M, Figueiredo FC, Rauz S, Mastropasqua L, Rama P, Baudouin C. Dua HS, et al. Among authors: mastropasqua l. Prog Retin Eye Res. 2018 Sep;66:107-131. doi: 10.1016/j.preteyeres.2018.04.003. Epub 2018 Apr 23. Prog Retin Eye Res. 2018. PMID: 29698813 Review.
Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management.
Roberti G, Oddone F, Agnifili L, Katsanos A, Michelessi M, Mastropasqua L, Quaranta L, Riva I, Tanga L, Manni G. Roberti G, et al. Among authors: mastropasqua l. Surv Ophthalmol. 2020 Jul-Aug;65(4):458-472. doi: 10.1016/j.survophthal.2020.01.002. Epub 2020 Feb 11. Surv Ophthalmol. 2020. PMID: 32057761 Review.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Refractive surgery and dry eye.
Mastropasqua L, Barboni P, Savini G, Aragona E, D'Aloisio R, Lanzini M, Agnifili L, Galzignato A, Solimeo A, Knutsson KA, Messmer EM. Mastropasqua L, et al. Eur J Ophthalmol. 2023 May 22:11206721231176312. doi: 10.1177/11206721231176312. Online ahead of print. Eur J Ophthalmol. 2023. PMID: 37218171
Welcoming teleretinography into diabetes integrated care.
Perilli R, Mariotti SP, Mastropasqua L, Bandello FM, Grigioni M, Tarricone R, Petracca F, Consoli A. Perilli R, et al. Among authors: mastropasqua l. Eur J Ophthalmol. 2022 Jul;32(4):2382-2387. doi: 10.1177/11206721211039346. Epub 2021 Aug 23. Eur J Ophthalmol. 2022. PMID: 34425693
Oxidative Stress Markers and the Retinopathy of Prematurity.
Graziosi A, Perrotta M, Russo D, Gasparroni G, D'Egidio C, Marinelli B, Di Marzio G, Falconio G, Mastropasqua L, Li Volti G, Mangifesta R, Gazzolo D. Graziosi A, et al. Among authors: mastropasqua l. J Clin Med. 2020 Aug 21;9(9):2711. doi: 10.3390/jcm9092711. J Clin Med. 2020. PMID: 32825796 Free PMC article. Review.
How many aqueous humor outflow pathways are there?
Costagliola C, dell'Omo R, Agnifili L, Bartollino S, Fea AM, Uva MG, Zeppa L, Mastropasqua L. Costagliola C, et al. Among authors: mastropasqua l. Surv Ophthalmol. 2020 Mar-Apr;65(2):144-170. doi: 10.1016/j.survophthal.2019.10.002. Epub 2019 Oct 14. Surv Ophthalmol. 2020. PMID: 31622628 Review.
290 results